Delivery Order SPE2DB22D1017-SPE2DB25FE8EB

Award Date 10/30/24
Potential Completion Date 10/31/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Imitrex 6 mg/0.5 mL cartridges. The $3,155.06 firm-fixed-price contract has a completion date of January 31, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $27,597.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Imitrex 6 mg/0.5 ml cartridges, a medication used to treat migraines. The contract is a firm-fixed-price delivery order with a period of performance through May 27, 2025. It is not designated as a set-aside contract, indicating open competition....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,809.77 contract is for the delivery of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a medication used to treat migraines. The contract has a period of performance through May 2, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,449.05, is for the delivery of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a medication used to treat migraines. The contract has an ultimate completion date of November 5, 2024 and is a firm fixed-price delivery order contract. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,970.03, is for the supply of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a medication used for the treatment of migraines. The contract is a firm fixed-price delivery order with an ultimate completion date of April 9, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp also holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Imitrex 6 mg/0.5 ml cartridges, a prescription medication used to treat migraines. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $2,049.45 and a performance period through May 2, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a $1,780.84 firm-fixed price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Imitrex 6 mg/0.5 ml pen injectors, a prescription medication used to treat migraines. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which provides a comprehensive global...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Imitrex 6 mg/0.5 ml cartridges, a migraine medication, with a ceiling value of $9,976.37. The contract is a firm fixed-price delivery order, with a completion date of June 24, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,739.10 firm fixed-price contract is for the supply of Imitrex 6 mg/0.5 ml cartridges, a specialty medication used in the treatment of migraines. The contract is not designated with a set-aside and has an ultimate completion date of November 22, 2024. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Imitrex, a prescription medication used to treat migraines, with a total ceiling value of $1,202.37. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen, valued at $999,999,999.00, which provides a comprehensive global...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FE8EB
    Delivery Order

This is a $1,263.83 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Imitrex 6 mg/0.5 ml cartridges, a prescription medication used to treat migraine headaches.

The contract is a firm fixed-price delivery order that is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/20/25, 1:45 PM